Impact of prophylaxis, inhibitors, and genetics on joint outcomes according to the IPSG-MRI score in hemophilia A, B and vWD type 3.
Frontiers in medicine
View this publicationFrontiers in medicine
View this publicationVaccine
View this publicationmedRxiv : the preprint server for health sciences
View this publicationSeminars in arthritis and rheumatism
View this publicationNature communications
View this publicationHuman genomics
View this publicationNature communications
View this publicationNaunyn-Schmiedeberg's archives of pharmacology
View this publicationCritical care (London, England)
View this publicationeLife
View this publication